CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignanciesFaroogh Marofi, Farhad Motavalli Khiavi, Roza Motavalli et al.|Stem Cell Research & Therapy|2021Cited by 76
Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal AdenocarcinomaMahboubeh Yazdanifar, Pinku Mukherjee|Cells|2019Cited by 61
RETRACTED: A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future DirectionsFaroogh Marofi, Mostafa Jarahian, Heshu Sulaiman Rahman et al.|Frontiers in Immunology|2021Cited by 48
Overcoming Immunological Resistance Enhances the Efficacy of a Novel anti-tMUC1 CAR T Cell Treatment Against Pancreatic Ductal AdenocarcinomaMahboubeh Yazdanifar, Pinku Mukherjee|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 22
Reconstructing the cell–cell interaction network among mouse immune cellsSomayeh Azadian, Nathan E. Lewis, Alireza Dostmohammadi et al.|Biotechnology and Bioengineering|2023Cited by 15